Skip to main content

Table 1 Demographic and clinical manifestations of JIA patients at enrollment

From: MicroRNA-27a-3p enhances the inflammatory phenotype of Juvenile Idiopathic Arthritis fibroblast-like synoviocytes

 

JIA Patients

Number of patients

8

Age at consent, years - mean (SD)

8.5 (5.5)

Sex – number (%)

 Male

3 (37%)

 Female

5 (63%)

ILAR classification – n (%)

 Oligoarticular arthritis

7 (88%)

 Extended oligoarticular arthritis

1 (12%)

Symptom duration, months – mean (SD)

19.3 (27.2)

ANA+ – number (%)

7 (83%)

Active joint count – mean (SD)

1.7 (1.0)

Medications - %

 Treatment naive

5 (63%)

 NSAIDs only

3 (37%)

  1. ILAR International League of Association for Rheumatology, ANA Antinuclear antibodies, NSAIDs Non-steroidal anti-inflammatory drugs